Clinical trial
Open Label Phase II Clinical Trial of Myoma Immunotherapy
NCT03550703 is registered in ClinicalTrials.gov with Immunitor LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Phase II Clinical Trial of Myoma Immunotherapy
- Lead sponsor
- Immunitor LLC
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- December 31, 2019
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.